Market cap of Tango Therapeutics Inc [TNGX] reaches 248.22M – now what?

Tango Therapeutics Inc [NASDAQ: TNGX] traded at a high on Monday, posting a 52.67 gain after which it closed the day’ session at $2.29.

The results of the trading session contributed to over 23497971 shares changing hands. Over the past one week, the price volatility of Tango Therapeutics Inc stands at 28.36% while the volatility over the past one month is 16.42%.

The market cap for TNGX stock reached $248.22 million, with 108.11 million shares outstanding and 58.92 million shares in the current float. Compared to the average trading volume of 741.36K shares, TNGX reached a trading volume of 23497971 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Tango Therapeutics Inc [TNGX]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNGX shares is $10.43 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNGX stock is a recommendation set at 1.12. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Jefferies have made an estimate for Tango Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 17, 2024. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on April 04, 2024, representing the official price target for Tango Therapeutics Inc stock. Previously, the target price had yet another raise to $18, while Piper Sandler analysts kept a Overweight rating on TNGX stock.

The Average True Range (ATR) for Tango Therapeutics Inc is set at 0.24, with the Price to Sales ratio for TNGX stock in the period of the last 12 months amounting to 6.06. The Price to Book ratio for the last quarter was 1.48, with the Price to Cash per share for the same quarter was set at 2.00.

How has TNGX stock performed recently?

Tango Therapeutics Inc [TNGX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 74.81. With this latest performance, TNGX shares gained by 77.52% in over the last four-week period, additionally sinking by -35.67% over the last 6 months – not to mention a drop of -70.64% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNGX stock in for the last two-week period is set at 72.84, with the RSI for the last a single of trading hit 79.92, and the three-weeks RSI is set at 66.34 for Tango Therapeutics Inc [TNGX]. The present Moving Average for the last 50 days of trading for this stock 1.4900, while it was recorded at 1.6000 for the last single week of trading, and 4.4700 for the last 200 days.

Tango Therapeutics Inc [TNGX]: Deeper insight into the fundamentals

Tango Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.26 and a Current Ratio set at 6.26.

Earnings analysis for Tango Therapeutics Inc [TNGX]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TNGX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Tango Therapeutics Inc go to -5.61%.

Insider trade positions for Tango Therapeutics Inc [TNGX]

The top three institutional holders of TNGX stocks are: TRV GP IV, LLC with ownership of 19.2 million shares, which is approximately 17.7276%. ECOR1 CAPITAL, LLC, holding 13.33 million shares of the stock with an approximate value of $$114.38 million in TNGX stocks shares; and ECOR1 CAPITAL, LLC, currently with $$80.73 million in TNGX stock with ownership which is approximately 8.6868%.